Skip to main content
. 2022 Sep 26;14(10):2044. doi: 10.3390/pharmaceutics14102044

Figure 5.

Figure 5

NIL10 reduce heart fibrosis in response to IR. (A) Representative immunoblot of MMP9 from healthy (H) or necrotic (N) areas of mouse hearts after 7 days of IR and injected with NIL10 or NIL10SC. n = 6 mice/group. Mean ± SD. * p < 0.001 NIL10 vs. NIL10SC necrotic areas. (B) Masson trichrome staining of heart sections from mice injected with NIL10 or NIL10SC, after 3 or 7 days post-IR (n = 6 mice/group). * p < 0.05 D3; ** p < 0.03 D7.